Haider Ali

Co-inoculation of Zymoseptoria tritici strains IPO323 and IPO88004. Co-inoculation experiments were performed with the avirulent strain IPO323 and the virulent strain IPO88004. Disease severity was evaluated across a series of virulent-to-avirulent ratios ranging from 1:10 to 1:1,000. Disease symptoms were recorded 21 days postinfection (dpi).

Haider Ali, Megan C. McDonald, and Graeme J. Kettles developed a rapid forward genetics methodology to identify genes that enable Zymoseptoria tritici to gain virulence on previously resistant wheat varieties. Learn more: doi.org/10.1094/MPMI...

🔬 New from the Farnung Lab: We established a fully in vitro reconstituted chromatin replication system and report the first cryo-EM snapshots of the human replisome engaging nucleosomes. Brilliant work by @felixsteinruecke.bsky.social with support from @jonmarkert.bsky.social! tinyurl.com/replisome

Image of person at a microscope with text explaining the BSPP Undergraduate Vacation Bursary. Projects run 6-8 weeks in the summer, students receive £450 per week. Students do not have to be BSPP members.

The @bspp.bsky.social Undergraduate Vacation Bursary Scheme applications are open🎉

Delighted to see the fantastic projects on offer! (I'm a little more biased than usual this year 😉)

📅 Deadline: April 14th
🔗 buff.ly/ZDo4pfK

👩‍🔬🍄🔥

Excited to be at #ECFG17! If you’re here, stop by my poster to chat about immune suppression by Zymoseptoria tritici effectors. Looking forward to great discussions! #PlantPathology #Zymo #Effectors

New Phytologist Stomata Seminar Video available (by Sally Assmann and myself). Thanks again for this fantastic opportunity to share our work and perspectives 🌱🥰!
cassyni.com/events/CpfRD...

HI old friends! Finally took the leap here to say I have several open positions going in my lab at the moment (and more to come).
1) PhD studentship in collaboration with the Royal Horticultural Society (genomics)
2) Biochemistry Postdoc to understand how Starships move

Check out the links below!

Please check our latest paper on using @deep-mind.bsky.social AlphaFold 3 to study NLR immune receptors. Here we use AI-guided structural modelling to distinguish between sensor and helper NLRs! 👇🧵 (1/10) #EvoMPMI #NLRbiology #PlantPath #PlantSci
doi.org/10.1101/2024...

Molecular basis of mRNA delivery to the bacterial ribosome Protein synthesis begins with the formation of a ribosome-messenger RNA (mRNA) complex. In bacteria, the small ribosomal subunit (30S) is recruited to many mRNAs through base pairing with the Shine-Da...

Structural basis of coupled transcription and translation in prokaryotes @science.org. Illuminating study - one for molecular genetics textbooks! 😍🧬👏

www.science.org/doi/10.1126/...

Ello ello, Zymo fellow!
Looking forward to your latest findings—exciting times for Zymo research!

Long-term survival of asexual Zymoseptoria tritici spores in the environment - BMC Biology Background The fungal phytopathogen Zymoseptoria tritici, causal agent of the economically damaging Septoria tritici blotch of wheat, is different from most foliar fungal pathogens in that its germina...

Latest publication from the Fones lab Exeter! "Long-term survival of asexual Zymoseptoria tritici spores in the environment" now out in @bmc biology! bmcbiol.biomedcentral.com/articles/10....

📢 Tomorrow! Join us for New Phytologist Now: Stomata – with Sally Assmann and Keiko Torii.

Live Q&A hosted by Hanna Hõrak.

15:30 GMT | 26 November

It's free to attend! Register now: us02web.zoom.us/webinar/regi...

Following the highly successful 46th New Phytologist Symposium: Stomata, we present two further talks from leading scientists Sally Assmann and Keiko Torii.

Register to attend New Phytologist Now online at 15:30 GMT, 26 November!

Live Q&A hosted by Hanna Hõrak.

us02web.zoom.us/webinar/regi...

Thrilled to announce Boltz-1, the first open-source and commercially available model to achieve AlphaFold3-level accuracy on biomolecular structure prediction! An exciting collaboration with Jeremy, Saro, and an amazing team at MIT and Genesis Therapeutics. A thread!